Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-01-10FDA Approved: POSLUMA — Supplemental Application (Blue Earth Diagnostics)
The FDA approved a supplemental application for POSLUMA (flotufolastat F-18) from Blue Earth Diagnostics, expanding its labeling for PET ima…
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Study to Evaluate a New Method to Detect Residual Tumours During Surgery for Prostate Cancer Using Confocal Microscopy [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating a new method that uses confocal microscopy to detect residual tumours during prostate cancer…
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Assessment of Supersonic Imagine Aixplorer for the Detection and Localisation of Prostate Cancer Foci [NA]
This clinical trial update reports the completion of a study evaluating the Supersonic Imagine Aixplorer ultrasound technology for detecting…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Experimental Study to Evaluate the Impact of 18 Fluoro-PSMA (18F-PSMA) PET / CT in the Management of Patients with Prostate Cancer. [Phase 2]
A Phase 2 clinical trial evaluating the impact of 18F-PSMA PET/CT in managing prostate cancer has completed, assessing how this imaging stra…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: 68Ga-PSMA HBED-PET/CT in the Evaluation of the Biochemical Relapse in Patients With a History of Prostate Cancer Radically Treated [NA]
A completed clinical trial evaluates Gallium-68 PSMA HBED-PET/CT imaging for evaluating biochemical relapse in men with a history of prostat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Physical Function During ARSI Treatment
A completed clinical trial update evaluating physical function in patients with advanced prostate cancer treated with androgen receptor sign…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Ibrutinib as Neoadjuvant Therapy in Localized Prostate Cancer [Phase 2]
Phase 2 trial evaluating Ibrutinib as neoadjuvant therapy for localized prostate cancer has completed, with results posted. The study was co…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer [Phase 1]
Phase 1 clinical trial investigating cyclophosphamide plus dexamethasone for metastatic castration-resistant prostate cancer; the study is c…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Study on the Efficacy and Mechanism of METTL3 Peptide Inhibitors in Enhancing Anti-tumor Immune Response by Reshaping the Tumor Microenvironment
This clinical trial update describes a study evaluating METTL3 peptide inhibitors to enhance the anti-tumor immune response by reshaping the…
-
CLINICAL_TRIALS withdrawal · 2025-01-08Clinical Trial Update: Dynamic Whole Body PET/ MRI
A clinical trial studying dynamic whole-body PET/MRI for prostate cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: Surgical Treatment With or Without Apalutamide in Subjects With High Risk Prostate Cancer Who Are Candidates for Radical Prostatectomy and Staged as Oligometastatic With PSMA-PET [Phase 2]
Phase 2 clinical trial evaluating surgical treatment with or without apalutamide in men with high-risk, oligometastatic prostate cancer stag…
-
FDA approval · 2025-01-03FDA Approved: BICALUTAMIDE — Supplemental Application (Viona Pharmaceuticals Inc.)
FDA approved a supplemental application for Bicalutamide from Viona Pharmaceuticals Inc., authorizing changes to the approved generic drug.
-
CLINICAL_TRIALS trial_result · 2025-01-03Clinical Trial Update: Effectiveness Evaluation of a Self-management Program for Prostate Cancer Survivors [NA]
The document reports the completed results of a trial evaluating a self-management program for prostate cancer survivors.
-
CLINICAL_TRIALS research · 2025-01-03Clinical Trial Update: Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metastasis [EARLY_Phase 1]
This EARLY Phase 1 trial compares two PET tracers, [18F]AlF-PSMA-N5 and [18F]F-DCFPyL, for diagnosing, monitoring recurrence, and detecting …
-
CLINICAL_TRIALS withdrawal · 2025-01-03Clinical Trial Update: Prostate MRI and Pylarify PSMA PET/CT [Phase 4]
A Phase 4 clinical trial evaluating prostate MRI and Pylarify PSMA PET/CT for prostate cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer [Phase 3]
A Phase 3 clinical trial evaluating 18F-Florastamin PET/CT imaging for suspected recurrence of prostate cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: A Technique Improves Urinary Continence in Patients Undergoing Laparoscopic Radical Prostatectomy [NA]
This clinical trial update describes a technique for posterior and anterior bladder wall reconstruction that may improve urinary continence …
-
CLINICAL_TRIALS trial_result · 2024-12-31Clinical Trial Update: Intensive Diet and Exercise or Standard of Care in Improving Physical Function and Quality of Life in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy [NA]
This clinical trial evaluated an intensive diet and exercise program versus standard of care to improve physical function and quality of lif…
-
CLINICAL_TRIALS trial_result · 2024-12-31Clinical Trial Update: Preoperative PSMA PET/CT As Triage for EPLND in Patients Scheduled for RALP (PrePSMA) [NA]
This clinical trial update reports ongoing recruitment for a study evaluating preoperative PSMA PET/CT as triage for extended pelvic lymph n…
-
CLINICAL_TRIALS other · 2024-12-30Clinical Trial Update: Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval
Agenus has launched an Expanded Access Program to provide Botensilimab and Balstilimab to patients before regulatory approval. The program t…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: A Randomized Controlled Trial to Improve the Therapeutic Effect of Robot-assisted Radical Prostatectomy (RARP) Using Indocyanine Green Fluorescence Imaging
A randomized controlled trial is evaluating whether indocyanine green fluorescence imaging can enhance the therapeutic effect of robot-assis…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Application of a Novel Biomarker Based on Plasma cfDNA Assay in the Early Diagnosis of Prostate Cancer
A clinical trial is evaluating a novel plasma cfDNA biomarker for early diagnosis of prostate cancer. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor [Phase 2]
Phase 2 trial evaluating 18F-PSMA PET/CT imaging for PSMA-positive tumors, with recruitment ongoing in China.
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: A Cluster Package Intervention to Promote an Evidence-based Use of PSA-tests in General Practice [NA]
This clinical trial update describes a cluster package intervention in general practice intended to promote evidence-based use of PSA tests …
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence [NA]
This clinical trial entry evaluates the efficacy of repeat stereotactic radiation for locally recurrent prostate cancer after initial treatm…